Giovanni Brandi
Azienda USL di Bologna(IT)
Publications by Year
Research Areas
Cholangiocarcinoma and Gallbladder Cancer Studies, Hepatocellular Carcinoma Treatment and Prognosis, Gallbladder and Bile Duct Disorders, Pancreatic and Hepatic Oncology Research, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial(2019)1,630 cited
- → The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses(2009)1,419 cited
- → Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy(2000)1,265 cited
- → Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial(2023)937 cited
- → Cholangiocarcinoma: Epidemiology and risk factors(2019)761 cited
- → ecancermedicalscience(2016)678 cited